Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

Growth Factor Research

CJC-1295 (with DAC)

In Stock

Price range: $99.00 through $221.00

CJC-1295 (With DAC) is a synthetic 29-amino-acid GHRH(1-29) analog chemically conjugated via a maleimidoproprionic acid linker to a Drug Affinity Complex (DAC), enabling reversible serum albumin binding with an estimated apparent half-life of approximately 5.8–8.1 days (pharmacokinetic model; Teichman et al., 2006). Designed for research into sustained GHRH receptor activation, long-term GH axis modulation, and metabolic models. Published lots are verified by HPLC (≥99% purity) and MS, with batch-specific third-party COAs in our Trust Center. Research use only — not for human or veterinary use.

99%+ Purity
Lab Tested
Fast Shipping
COA Available
SKU: N/A Category:

Description

/* Reset & Base */
* {
box-sizing: border-box;
margin: 0;
padding: 0;
}
body {
font-family: ‘Inter’, -apple-system, BlinkMacSystemFont, ‘Segoe UI’, Roboto, Helvetica, Arial, sans-serif;
background: #fff;
color: #1e1e1e;
line-height: 1.6;
}
/* Utilities */
.sm-container {
max-width: 1300px;
margin: 0 auto;
padding: 20px 32px 60px;
width: 100%;
}
.sm-flex {
display: flex;
flex-wrap: wrap;
}
.sm-grid-2 {
display: grid;
grid-template-columns: 1fr 1fr;
gap: 40px;
}
.sm-grid-3 {
display: grid;
grid-template-columns: repeat(3, 1fr);
gap: 24px;
}
.sm-grid-4 {
display: grid;
grid-template-columns: repeat(4, 1fr);
gap: 20px;
}
/* Tabs */
.sm-tab-input {
display: none;
}
.sm-panel {
display: none;
}
#sm-tab-product:checked~.sm-tab-nav label[for=”sm-tab-product”],
#sm-tab-disclaimer:checked~.sm-tab-nav label[for=”sm-tab-disclaimer”] {
background: #F27444;
color: #fff;
border-color: #F27444;
box-shadow: 0 8px 20px rgba(242, 116, 68, 0.25);
}
#sm-tab-product:checked~.sm-product-panel {
display: block;
}
#sm-tab-disclaimer:checked~.sm-disclaimer-panel {
display: block;
}
/* FAQ */
.sm-faq summary::-webkit-details-marker {
display: none;
}
.sm-faq[open] .sm-plus {
transform: rotate(45deg);
}
/* Chips */
.sm-chip {
display: inline-block;
padding: 8px 16px;
border-radius: 999px;
background: #fff4ef;
border: 1px solid #ffd9cb;
color: #F27444;
font-weight: 600;
font-size: 0.9rem;
margin: 4px 6px 4px 0;
letter-spacing: 0.02em;
}
/* Cards & Hover */
.sm-card {
background: #fff;
border: 1px solid #f0e8e4;
border-radius: 28px;
padding: 28px;
transition: all 0.2s ease-in-out;
}
.sm-card:hover {
transform: translateY(-4px);
box-shadow: 0 20px 40px -12px rgba(0, 0, 0, 0.08);
border-color: #F27444;
}
.sm-card-glow {
background: linear-gradient(135deg, #fff 0%, #fff8f5 100%);
border: 1px solid #ffe1d6;
}
/* Specs Zebra */
.sm-spec-grid {
display: grid;
grid-template-columns: 1fr 1fr;
}
.sm-spec-item {
padding: 16px 24px;
border-bottom: 1px solid #f0e8e4;
background: #fff;
}
.sm-spec-item:nth-child(odd) {
background: #fcfaf9;
}
/* Buttons (removed all price/order elements) */
.sm-btn {
display: none; /* completely hide any leftover buttons */
}
/* Responsive */
@media(max-width:768px) {
.sm-container {
padding: 20px 16px 40px;
}
.sm-grid-2,
.sm-grid-3,
.sm-grid-4 {
grid-template-columns: 1fr !important;
gap: 20px;
}
.sm-spec-grid {
grid-template-columns: 1fr;
}
.sm-tab {
width: 100% !important;
text-align: center !important;
}
.sm-hero-title {
font-size: 32px !important;
}
h2 {
font-size: 24px !important;
}
}
/* Misc */
.sm-tab {
font-size: 1rem;
padding: 12px 32px;
border-radius: 999px;
background: #fff;
border: 1px solid #e0d6d0;
color: #1e1e1e;
cursor: pointer;
font-weight: 600;
transition: all 0.2s;
user-select: none;
}
.sm-tab:hover {
background: #fff4ef;
border-color: #F27444;
}
.sm-hero-bg {
background: radial-gradient(ellipse at 70% 20%, rgba(242, 116, 68, 0.04) 0%, rgba(255, 255, 255, 0) 70%);
}
/* Reference list item hover */
.ref-item {
padding: 16px 20px;
background: #fff;
border-radius: 16px;
border: 1px solid #f0e8e4;
transition: all 0.2s ease-in-out;
}
.ref-item:hover {
border-color: #F27444;
box-shadow: 0 4px 12px rgba(242, 116, 68, 0.08);
}
.ref-item a {
color: #F27444;
font-weight: 700;
text-decoration: none;
}
.ref-item a:hover {
text-decoration: underline;
}




SaiyanMed Research Grade

CJC-1295 (With DAC)

Long-acting GHRH Analog with Drug Affinity Complex

Research-grade CJC-1295 (With DAC) is a synthetic 29-amino-acid peptide analog of growth hormone-releasing hormone (GHRH) chemically conjugated with a Drug Affinity Complex (DAC) — a maleimidoproprionic acid linker that facilitates reversible binding to serum albumin. This albumin-binding extends the estimated apparent half-life to approximately 5.8–8.1 days (based on pharmacokinetic modeling in clinical studies; Teichman et al., 2006), enabling sustained GHRH receptor activation for laboratory research. Each vial is lyophilized, ≥99% HPLC pure, MS-confirmed, and supported by batch-specific third-party COAs published in our Trust Center. For research use only — not for human or veterinary use.

≥99% HPLC
MS Confirmed
Third-Party COA
Lyophilized
Est. 5.8–8.1 day half-life
Global Warehouse Fulfillment

Long-Acting GHRH Analog

GHRHR · Class B GPCR

Designed for research models studying sustained GHRH-receptor activation, GH-axis long-term modulation, and comparative pharmacology against pulsatile analogs such as CJC-1295 (No DAC) and sermorelin.

29 AA + DAC
CAS 446262-90-4
RUO

Research Context

Sustained GHRH Agonist

CJC-1295 (With DAC) is positioned for mechanistic research into long-term GHRH-receptor signaling and sustained growth-hormone-axis modulation, offering a distinct pharmacokinetic profile (estimated half-life of several days) compared to short-acting pulsatile analogs.

GHRHR Agonism
Sustained GH
Metabolic Research
Albumin-Binding

What is CJC-1295 (With DAC)?

CJC-1295 (With DAC) is a synthetic 29-amino-acid peptide analog of growth hormone-releasing hormone (GHRH) chemically conjugated with a Drug Affinity Complex (DAC). The DAC moiety, a maleimidoproprionic acid linker, enables covalent but reversible binding to serum albumin. This albumin-binding extends the peptide’s apparent half-life, with published clinical data (Teichman et al., 2006) reporting a pharmacokinetic model-derived estimate of 5.8–8.1 days.

Unlike short-acting GHRH analogs such as sermorelin (half-life ~10–15 minutes) or CJC-1295 (No DAC) (half-life ~30 minutes), which produce pulsatile GH release, CJC-1295 (With DAC) provides sustained GHRH receptor activation, driving continuous GH secretion and downstream IGF-1 elevation. This makes it a research tool for studying prolonged GHRH agonism on the growth hormone axis, metabolism, and body composition in laboratory settings.

It serves as a reference molecule for comparative pharmacology studies evaluating pulsatile vs. sustained GHRH receptor activation and has been characterized in preclinical and early-phase clinical research models.

🧪 Research Applications

①

Sustained GHRH Receptor Activation

Long-acting GHRH agonism via albumin-bound DAC — for prolonged receptor stimulation studies (estimated half-life of several days).

②

GH Axis Long-Term Modulation

Sustained GH and IGF-1 elevation research — studying chronic GHRH signaling effects on the somatotropic axis.

③

Metabolic & Body Composition Models

Investigating GH-mediated metabolic effects, lipid metabolism, and body composition in research models.

④

Comparative GHRH Pharmacology

CJC-1295 (With DAC) vs (No DAC) vs sermorelin — sustained vs pulsatile GHRH agonist profiling.

⑤

Albumin-Binding & PK Studies

Drug Affinity Complex mechanism research — albumin interaction, half-life extension, and pharmacokinetics.

⑥

Dual Pathway Stacking (Exploratory)

Hypothesis-driven research exploring combination with GHSR-1a agonists (e.g., ipamorelin) for synergistic GH-axis modulation.

📊 Quick Specs

Form: Lyophilized powder (white to off-white)
Purity: ≥99% by HPLC
Identity: MS molecular-weight confirmed
CAS Number: 446262-90-4 (With DAC)
Also Known As: CJC-1295 with DAC; DAC-GHRH
Peptide Length: 29 amino acids (GHRH 1-29) + DAC chemical conjugate
Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: 3647.19 Da
Receptor Target: GHRH receptor (GHRHR, class B GPCR)
Modification: Drug Affinity Complex (DAC) — maleimidoproprionic acid linker for albumin binding
Apparent Half-Life: Estimated 5.8–8.1 days (pharmacokinetic model; Teichman et al., 2006)
Peptide Type: Long-acting GHRH analog
COA: Third-party lab tested — batch-specific, publicly verifiable
Manufacture: Lyophilized & QC-released in-house
Storage: −20°C sealed | 2–8°C reconstituted
Shelf Life: 24 months unopened (lyophilized)
Category: Peptides · Performance & Hormone Optimization

VERIFIED

Certificate of Analysis

Independent Third-Party Analytical Testing

Quality assurance includes orthogonal analytical testing by an independent analytical service provider. Each resulting Certificate of Analysis (COA) includes specific HPLC chromatograms and MS spectra. End‑users may cross‑reference the document via the SaiyanMed Trust Center using the unique batch identifier printed on the vial label.

Batch‑specific documentation supports traceability for laboratory records. Always confirm the batch reference matches the product vial before use.

📦 Storage & Handling

🧊 Storage

Lyophilized vials: store at −20°C, sealed, protected from light and moisture. After reconstitution: store at 2–8°C and use within 3–4 weeks (study-defined stability window). Avoid repeated freeze-thaw cycles. The DAC moiety is sensitive to extreme pH and prolonged light exposure — handle with care. Do not use if the reconstituted solution is cloudy or contains visible particles.

💧 Reconstitution

Add 1–2 mL of sterile diluent (bacteriostatic water or sterile saline) slowly down the inside wall of the vial. Do not shake or vortex; swirl gently until fully dissolved. The resulting solution should be clear and colorless. Prepare working dilutions according to your laboratory protocol. Reconstituted CJC-1295 (With DAC) is stable at 2–8°C for up to 4 weeks.

🚚 Fulfillment & Transit Notice

Global logistics: To maintain structural integrity, lyophilized peptides are shipped in thermally insulated packaging. While in transit, the product remains stable at ambient temperatures for the typical 7–14 day window. Upon arrival, immediate refrigeration at −20°C is recommended.

Warehouse origin: We strategically ship from the nearest fulfillment center to reduce transit time. US orders are dispatched domestically; international orders ship from our Asian logistics hub (estimated 7–14 business days).

Customs & duties: While we handle export documentation, import duties or customs inspections are standard procedures for research chemicals and remain the responsibility of the consignee. Delays due to customs are a normal part of international shipping and do not indicate a product issue.

Delays or holds: If your shipment exceeds the estimated window or is held in customs, contact us with your order reference. Our support team will intervene with tracking and carrier coordination, and where applicable, arrange a reshipment per our policy.

Damaged or incorrect items: Inspect your order immediately upon arrival. If a vial is damaged or an item is incorrect, contact us within the stated policy period with photos for prompt resolution.


⚠️

Research Use Only

This material is supplied only for qualified laboratory research and is not intended for human or veterinary use.

Research Use Only

Not for Human Consumption

SaiyanMed products are strictly for in vitro and in vivo laboratory research. They are not intended for diagnostic, therapeutic, medical, disease-prevention, consumer health, or personal use.

All SaiyanMed products are supplied for laboratory, scientific, and research use only. They are not for human consumption, medical treatment, diagnosis, disease prevention, or veterinary use.

✅ Buyer Confirmation

✓ You are a qualified researcher or acting under the supervision of one.

✓ Products will only be used for legitimate research purposes.

✓ Products are not evaluated by the FDA or any regulatory authority for human use.

✓ You assume responsibility for legal compliance, proper handling, storage, and disposal.

No Warranty: Products are sold “as is,” with no express or implied warranties regarding efficacy, safety, or suitability. Results in research may vary. SaiyanMed is not responsible for outcomes, interpretations, or conclusions drawn from any studies conducted using these products.

🛡️ General Safety & Handling

🚫 Not for Human Use
These compounds are for research only. Any off-label, personal, or clinical use is outside the intended scope.

🥽 PPE Required
Always use appropriate personal protective equipment, including gloves, lab coat, and eye protection.

🌡 Storage Compliance
Follow product-specific storage conditions to maintain identity, purity, and biological activity.

🗑 Proper Disposal
Dispose of all materials according to institutional biosafety, chemical waste, and hazardous material protocols.

🧾 Verify Quality
Verify batch identity, MS confirmation, HPLC purity, and COA status before research use.

⚖ Legal Compliance
Researchers are responsible for lawful purchase, possession, storage, and use in their jurisdiction.

💬 Frequently Asked Questions

What is CJC-1295 (With DAC) used for?+

CJC-1295 (With DAC) is supplied strictly as a research reference compound for in vitro and in vivo laboratory study of sustained GHRH-receptor signaling, long-term GH-axis modulation, and metabolic research models. It is not for human or veterinary use.

How is CJC-1295 (With DAC) different from CJC-1295 (No DAC) or Sermorelin?+

CJC-1295 (With DAC) features a Drug Affinity Complex (DAC) that covalently binds to serum albumin via a maleimidoproprionic acid linker, extending its apparent half-life to an estimated 5.8–8.1 days (based on pharmacokinetic modeling) for sustained GHRH receptor activation. CJC-1295 (No DAC) and sermorelin are short-acting, producing pulsatile GH release with half-lives of ~30 minutes and ~10–15 minutes, respectively. With DAC is used for studying prolonged GHRH agonism, while No DAC is used for pulsatile signaling research.

How is purity verified?+

Each production lot is subjected to quantitative HPLC (≥99% purity) and high‑resolution mass spectrometry for identity confirmation. A third-party COA is published for tested batches and is independently verifiable online via the batch‑specific identifier.

How should it be stored?+

Lyophilized vials should be kept at −20°C, away from light and moisture. After reconstitution with sterile diluent, store at 2–8°C and use within 3–4 weeks. Avoid repeated freeze‑thaw cycles and protect from light, as the DAC moiety is sensitive to extreme pH and prolonged light exposure.

Where does it ship from?+

Orders are dispatched from the nearest available warehouse – US domestic orders from our US fulfillment center, international orders from our Asian hub. Estimated delivery is 7–14 days for global shipments, with tracking provided.

Is this intended for human use?+

No. This material is strictly for laboratory research use only and is not intended for human consumption, diagnosis, treatment, disease prevention, or any personal use. It is not a pharmaceutical product.


📚 References


Teichman SL, Neale A, Lawrence B, et al. (2006):
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
J Clin Endocrinol Metab 91(3):799-805. PMID: 16352683.
Key pharmacokinetic findings: single-dose CJC-1295 increased GH 2-10× for ≥6 days and IGF-I 1.5-3× for 9-11 days (single dose). Estimated apparent half-life: 5.8–8.1 days (pharmacokinetic model). IGF-I remained elevated for up to 28 days after multiple-dose regimens.
View at PubMed (PMID: 16352683) ↗

PubChem Compound Summary:
CJC-1295 (With DAC) – molecular formula C₁₆₅H₂₆₉N₄₇O₄₆, molecular weight 3647.19, CAS 446262-90-4.
View PubChem Compound Summary (CAS 446262-90-4) ↗

ClinicalTrials.gov (NCT00091286):
Pharmacokinetics/Pharmacodynamics of CJC-1295 in Healthy Volunteers (Phase 1).
View NCT00091286 ↗

ClinicalTrials.gov (NCT00357318):
CJC-1295 in Growth Hormone Deficient Patients (Phase 2).
View NCT00357318 ↗

CJC-1295 has been investigated as an Investigational New Drug (IND) in Phase 1 and Phase 2 trials. Not FDA-approved for therapeutic use.

Bridon DP, Boudjellab N, Leger R, et al. (2002):
Long lasting growth hormone releasing factor derivatives.
Foundational patent describing CJC-1295 and DAC technology. WO 2004/003179 A2.
View WO 2004/003179 A2 ↗

Additional information

Concentration & Vial

2mg × 10 vials, 5mg x 10 vials

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (with DAC)”

Your email address will not be published. Required fields are marked *